Mvasi and Joint pain - a phase IV clinical study of FDA data

Summary:

Joint pain is reported as a side effect among people who take Mvasi (bevacizumab-awwb), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Ondansetron, and have Diarrhea.

The phase IV clinical study analyzes which people have Joint pain when taking Mvasi. It is created by eHealthMe based on reports of 3,295 people who have side effects when taking Mvasi from the FDA, and is updated regularly.

What is Mvasi?

Mvasi has active ingredients of bevacizumab-awwb. eHealthMe is studying from 3,295 Mvasi users. Check the latest studies of Mvasi.

What is Joint pain?

Joint pain is found to be associated with 3,328 drugs and 5,212 conditions by eHealthMe. Check the latest studies of Joint pain.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

3,295 people reported to have side effects when taking Mvasi.
Among them, 33 people (1.0%) have Joint pain.

Among these 33 people:

How long have people been on Mvasi when they have Joint pain? *

What is the gender of people who have Joint pain when taking Mvasi? *

female: 40.74 %
male: 59.26 %

What is the age of people who have Joint pain when taking Mvasi? *

What are other drugs people take besides Mvasi? *

What are other side effects people have besides Joint pain? *

Fatigue (feeling of tiredness): 10 people, 30.30%
Weakness: 9 people, 27.27%
Headache (pain in head): 9 people, 27.27%
Dizziness: 9 people, 27.27%
Pain In Extremity: 8 people, 24.24%
Nausea (feeling of having an urge to vomit): 7 people, 21.21%
Diarrhea: 7 people, 21.21%
Stress And Anxiety: 5 people, 15.15%
Anaemia (lack of blood): 5 people, 15.15%
Axillary Mass: 5 people, 15.15%

What are the existing conditions these people have? *

Diarrhea: 9 people, 27.27%
Pain: 8 people, 24.24%
Oligodendroglioma (a type of glioma that are believed to originate from the oligodendrocytes of the brain or from a glial precursor cell): 5 people, 15.15%
Dizziness: 5 people, 15.15%
Nausea (feeling of having an urge to vomit): 4 people, 12.12%
Colon Cancer: 4 people, 12.12%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 4 people, 12.12%
Neuralgia (pain in one or more nerves): 4 people, 12.12%
Nausea And Vomiting: 4 people, 12.12%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 12.12%

* Approximation only. Some reports may have incomplete information.

Do you take Mvasi and have Joint pain?

- Check whether Joint pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mvasi:

Mvasi (3,295 reports)

Joint pain treatments and more:

Joint pain (542,936 reports)

Browse all side effects of Mvasi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint pain:

Joint pain (3,328 drugs)

Browse all the conditions that are associated with Joint pain:

Joint pain (5,212 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bevacizumab-awwb (the active ingredients of Mvasi) and Mvasi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.